The development of peptide-based tools for the analysis of angiogenesis

Chemistry and Biology

Volumn 18, Issue 7, 2011, Pages 839-845

  Fedorova, Anna ^a   Zobel, Kerry ^a   Gill, Herman S ^a   Ogasawara, Annie ^a   Flores, Judith E ^a   Tinianow, Jeff N ^a   Vanderbilt, Alexander N ^a   Wu, Ping ^a   Meng, Y Gloria ^a   Williams, Simon P ^a   Wiesmann, Christian ^b   Murray, Jeremy ^a   Marik, Jan ^a   Deshayes, Kurt ^a  

^a GENENTECH INC   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

PEPTIDE; PEPTIDE LIBRARY; VASCULOTROPIN A;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; CLICK CHEMISTRY; HUMAN; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; MOUSE; NEOPLASM; NUDE MOUSE; POSITRON EMISSION TOMOGRAPHY; PROTEIN BINDING; PROTEIN MULTIMERIZATION; SCINTISCANNING; SYNTHESIS; X RAY CRYSTALLOGRAPHY;

AMINO ACID SEQUENCE; ANIMALS; CLICK CHEMISTRY; CRYSTALLOGRAPHY, X-RAY; HUMANS; MICE; MICE, NUDE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NEOPLASMS; PEPTIDE LIBRARY; PEPTIDES; POSITRON-EMISSION TOMOGRAPHY; PROTEIN BINDING; PROTEIN MULTIMERIZATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79960947751     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2011.05.011     Document Type: Article

References (25)

1. R.C. Bailey Grand challenge commentary: informative diagnostics for personalized medicine Nat. Chem. Biol. 6 2010 857 859
2. S. Basu Personalized versus evidence-based medicine with PET-based imaging Nat. Rev. Clin. Oncol. 7 2010 665 668
3. H.W. Christinger, Y.A. Muller, L.T. Berleau, B.A. Keyt, B.C. Cunningham, N. Ferrara, and A.M. de Vos Crystallization of the receptor binding domain of vascular endothelial growth factor Proteins 26 1996 353 357 (Pubitemid 26405007)
4. A.S. Chung, J. Lee, and N. Ferrara Targeting the tumour vasculature: insights from physiological angiogenesis Nat. Rev. Cancer 10 2010 505 514
5. A. Dowlati, R. Gray, A.B. Sandler, J.H. Schiller, and D.H. Johnson Cell adhesion molecules, vascular endothelial growth factor, and basic fibroblast growth factor in patients with non-small cell lung cancer treated with chemotherapy with or without bevacizumab - an Eastern Cooperative Oncology Group Study Clin. Cancer Res. 14 2008 1407 1412 (Pubitemid 351413922)
6. N. Ferrara, and T. Davis-Smyth The biology of vascular endothelial growth factor Endocr. Rev. 18 1997 4 25 (Pubitemid 27076453)
7. M. Friedman, E. Nordberg, I. Höidén-Guthenberg, H. Brismar, G.P. Adams, F.Y. Nilsson, J. Carlsson, and S. Sthl Phage display selection of Affibody molecules with specific binding to the extracellular domain of the epidermal growth factor receptor Protein Eng. Des. Sel. 20 2007 189 199 (Pubitemid 351321300)
8. 18F exemplified by quantitative positron emission tomography of human epidermal growth factor receptor 2 J. Med. Chem. 52 2009 5816 5825
9. J.S. Heier, A.N. Antoszyk, P.R. Pavan, S.R. Leff, P.J. Rosenfeld, T.A. Ciulla, R.F. Dreyer, R.C. Gentile, J.P. Sy, G. Hantsbarger, and N. Shams Ranibizumab for treatment of neovascular age-related macular degeneration: a phase I/II multicenter, controlled, multidose study Ophthalmology 113 2006 633.e631 633.e634
10. E.M. Hendriksen, P.N. Span, J. Schuuring, J.P. Peters, F.C. Sweep, A.J. van der Kogel, and J. Bussink Angiogenesis, hypoxia and VEGF expression during tumour growth in a human xenograft tumour model Microvasc. Res. 77 2009 96 103
11. H. Hurwitz, L. Fehrenbacher, W. Novotny, T. Cartwright, J. Hainsworth, W. Heim, J. Berlin, A. Baron, S. Griffing, and E. Holmgren Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer N. Engl. J. Med. 350 2004 2335 2342 (Pubitemid 38702844)
12. 18F]FBEM-Z(HER2:342)-Affibody molecule - a new molecular tracer for in vivo monitoring of HER2 expression by positron emission tomography Eur. J. Nucl. Med. Mol. Imaging 35 2008 1008 1018
13. W.C. Liang, X. Wu, F.V. Peale, C.V. Lee, Y.G. Meng, J. Gutierrez, L. Fu, A.K. Malik, H.P. Gerber, N. Ferrara, and G. Fuh Cross-species vascular endothelial growth factor (VEGF)-blocking antibodies completely inhibit the growth of human tumor xenografts and measure the contribution of stromal VEGF J. Biol. Chem. 281 2006 951 961
14. Y.A. Muller, Y. Chen, H.W. Christinger, B. Li, B.C. Cunningham, H.B. Lowman, and A.M. de Vos VEGF and the Fab fragment of a humanized neutralizing antibody: crystal structure of the complex at 2.4 A resolution and mutational analysis of the interface Structure 6 1998 1153 1167 (Pubitemid 28434118)
15. A. Orlova, M. Magnusson, T.L. Eriksson, M. Nilsson, B. Larsson, I. Höidén-Guthenberg, C. Widström, J. Carlsson, V. Tolmachev, S. Sthl, and F.Y. Nilsson Tumor imaging using a picomolar affinity HER2 binding Affibody molecule Cancer Res. 66 2006 4339 4348
16. B. Pan, B. Li, S.J. Russell, J.Y. Tom, A.G. Cochran, and W.J. Fairbrother Solution structure of a phage-derived peptide antagonist in complex with vascular endothelial growth factor J. Mol. Biol. 316 2002 769 787 (Pubitemid 34729253)
17. 68Ga for PET imaging of HER2 expression J. Nucl. Med. 50 2009 1492 1499
18. A. Sandler, R. Gray, M.C. Perry, J. Brahmer, J.H. Schiller, A. Dowlati, R. Lilenbaum, and D.H. Johnson Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer N. Engl. J. Med. 355 2006 2542 2550 (Pubitemid 44917502)
19. S.S. Sidhu, W.J. Fairbrother, and K. Deshayes Exploring protein-protein interactions with phage display ChemBioChem 4 2003 14 25 (Pubitemid 36114206)
20. S.S. Sidhu, B.K. Feld, and G.A. Weiss M13 bacteriophage coat proteins engineered for improved phage display Methods Mol. Biol. 352 2007 205 219
21. M.A. Starovasnik, A.C. Braisted, and J.A. Wells Structural mimicry of a native protein by a minimized binding domain Proc. Natl. Acad. Sci. USA 94 1997 10080 10085 (Pubitemid 27406997)
22. G.A. van Dongen, G.W. Visser, M.N. Lub-de Hooge, E.G. de Vries, and L.R. Perk Immuno-PET: a navigator in monoclonal antibody development and applications Oncologist 12 2007 1379 1389
23. L.J. van't Veer, and R. Bernards Enabling personalized cancer medicine through analysis of gene-expression patterns Nature 452 2008 564 570 (Pubitemid 351483370)
24. C. Wiesmann, H.W. Christinger, A.G. Cochran, B.C. Cunningham, W.J. Fairbrother, C.J. Keenan, G. Meng, and A.M. de Vos Crystal structure of the complex between VEGF and a receptor-blocking peptide Biochemistry 37 1998 17765 17772 (Pubitemid 29023931)
25. C. Wiesmann, G. Fuh, H.W. Christinger, C. Eigenbrot, J.A. Wells, and A.M. de Vos Crystal structure at 1.7 A resolution of VEGF in complex with domain 2 of the Flt-1 receptor Cell 91 1997 695 704 (Pubitemid 27513660)